Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Non-fasting Conditions
Clinical trial NCT00830024 · COMPLETED
Trial details
- NCT number
- NCT00830024
- Sponsor
- Teva Pharmaceuticals USA
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-01
- Primary completion
- 2005-06-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.